trial

OnTrackNY's Learning Healthcare System

NCTId NCT04021719
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Suspended
Enrollment 2,100 (estimated)
Sponsored by New York State Psychiatric Institute, Washington Heights Community Service
Primary completion 2026-12-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Suspended
Enrollment
2,100 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2019-08-15
Primary completion
2026-12-30
Eligibility
ALL · 16 Years

Interventions & indications

Drugs
Stakeholder feedbackData infrastructure

Sponsors

New York State Psychiatric Institute, Washington Heights Community ServiceLead Sponsor
Columbia UniversityCollaborator
New York UniversityCollaborator
Washington University School of MedicineCollaborator
National Institute of Mental Health (NIMH)Collaborator

Investigators

2
Lisa B Dixon, MD, MPHPrincipal Investigator
Iruma Bello, PhDPrincipal Investigator

Sites

1 total
New York, United States

Facts & assertions

4 sourced
Enrollment
2,100
Phase
NA
Primary Completion Date
2026-12-30
Status
SUSPENDED
relationships
The graph out of here
drug
Stakeholder feedback
drug
Data infrastructure
drug
lead_sponsor
New York State Psychiatric Institute, Washington Heights Community Service
company
collaborator
Columbia University
company
New York University
company
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
Mental Disorders
indication
First Episode Psychosis
indication
investigator
Lisa B Dixon, MD, MPH
person
Iruma Bello, PhD
person